New Migraine Drugs Show Promise

WEDNESDAY, Nov. 29, 2017 (HealthDay News) — Two new migraine drugs have shown promise in late-stage clinical trials. The drugs were designed specifically to target a pathway believed to be important in these headaches. In stage 3 clinical trials, the drugs were found to work exceptionally well for some people, but not as well for…

Details